Home LiteratureArticle Details
PMID: 3874261 Published · ppublish English Journal Article

Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation.

The Journal of general virology ·Vol. 66 ( Pt 6) ·1985-06-00 ·Pages 1327-31

Wraith DC, Askonas BA

Abstract

An ammonium deoxycholate fraction from bromelain-treated influenza A virus was highly enriched for virus nucleoprotein and contained residual haemagglutinin (NP/HA). The preparation did not contain detectable levels of matrix or neuraminidase proteins and was free of infectious virus. NP/HA effectively primed mice for cytotoxic T cells which lysed syngeneic cells infected with any type A influenza virus. Furthermore, NP/HA generated A-type virus cross-reactive cytotoxic T cells when added in vitro to spleen cells from mice previously primed with infectious influenza A virus. These properties imply that NP/HA has potential as a vaccine for heterotypic influenza A immunity.

MeSH Terms
Animals Cross Reactions Hemagglutinins, Viral/immunology,isolation & purification Immunization Influenza A virus/immunology Mice Mice, Inbred BALB C Nucleoproteins/immunology,isolation & purification T-Lymphocytes, Cytotoxic/immunology Viral Matrix Proteins Viral Proteins/immunology,isolation & purification
Chemicals
Hemagglutinins, Viral Nucleoproteins Viral Matrix Proteins Viral Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wraith D C
Askonas B A
Article Info
Journal
The Journal of general virology
Abbr.
J Gen Virol
ISSN
0022-1317
Published
1985-06-00
Pages
1327-31
Language
English
Region
England
NLM ID
0077340
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]